Articles liés à Inflammatory Mechanisms in Mediating Hearing Loss

Inflammatory Mechanisms in Mediating Hearing Loss - Couverture rigide

 
9783319925066: Inflammatory Mechanisms in Mediating Hearing Loss

Synopsis

Common forms of preventable hearing loss are drug and noise-induced hearing loss which are believed to be produced by a similar mechanism. The generation of reactive oxygen species appears to be a common mechanism mediating hearing loss produced by these different sources. As such, a number of laboratories have focused their research towards identifying the sources of ROS production in the cochlea following administration of chemotherapeutic agents or noise exposure. This led to the identification of ROS generating enzymes, such as xanthine oxidases, nitric oxide synthase, and NADPH oxidases which are activated and/or induced during the development of hearing loss. A consequence of these findings was the implementation of antioxidants in preclinical studies for the treatment of hearing loss. These antioxidants have provided different levels of protection in animal and human studies, but none of these have been approved by the US Food and Drug Administration for the treatmentof hearing loss.

More recently, it was shown that noise-induced hearing loss was associated with recruitment of inflammatory cells and mediators in the cochlea. This finding would suggest that noise could produce injury to the cochlea which stimulates local and/or circulating inflammatory cells. A similar finding was observed in the cochlea following administration of the anticancer drug, cisplatin. In addition, our laboratory and others have provided a plausible mechanism by which noise or chemotherapeutic agents could stimulate the inflammatory response. Surprisingly, this mechanism involves ROS activation of transcription factors linked to inflammatory processes in the cochlea. These studies have led to the use of anti-inflammatory agents for the treatment of hearing loss. Preliminary studies targeting inflammatory cytokines appear especially promising in preclinical studies.

A primary goal of this project is to describe our current understanding of theoxidant hypothesis of noise and drug-induced hearing loss and show how this relates to cochlear inflammation. Several different aspects of the cochlear inflammatory process will be discussed in detail, ranging from the sources of inflammatory cells, chemokines, inflammatory cytokines, and cochlea resident immune cells. Molecular pathways leading to activation of the local inflammatory process will be highlighted and treatment options will be discussed. The relevance of certain clinically used anti-inflammatory interventions, such as trans-typmanic steroids will also be discussed. Furthermore, we will examine recent patents focusing on the use of anti-inflammatory agents for the treatment of drug and noise-induced hearing loss.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

À propos de l?auteur

Vickram Ramkumar, Ph.D., joined the faculty at Southern Illinois University School of Medicine in 1992. He is a professor of pharmacology.
Previously he was a research associate in cardiology at Duke University Medical Center in Durham, N.C. (1986-92).
Ramkumar is the author of more than 65 articles. His research interest is the molecular pharmacology of adenosine receptors in cardiovascular and auditory systems and cellular signal transduction processes.

Dr. Leonard P. Rybak, is a professor and ear, nose and throat specialist whose general otolaryngology practice focuses on sinus disease and obstructive sleep apnea.
Dr. Rybak's professional affiliations include the American College of Surgeons, and the American Academy of Otolaryngology -- Head and Neck Surgery. Locally, he is a member of the Sangamon County Medical Society and of various committees at St. John's Hospital and the SIU School of Medicine. He serves as president of the Sangamon County Chapter of the Society for Neuroscience.

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.

Acheter D'occasion

x, 231 p. Hardcover. Versand aus...
Afficher cet article

EUR 10 expédition depuis Allemagne vers France

Destinations, frais et délais

Acheter neuf

Afficher cet article
EUR 92,27

Autre devise

EUR 9,70 expédition depuis Allemagne vers France

Destinations, frais et délais

Autres éditions populaires du même titre

9783030064471: Inflammatory Mechanisms in Mediating Hearing Loss

Edition présentée

ISBN 10 :  3030064476 ISBN 13 :  9783030064471
Editeur : Springer, 2019
Couverture souple

Résultats de recherche pour Inflammatory Mechanisms in Mediating Hearing Loss

Image d'archives

Ramkumar, V. et al (Eds.)
Edité par Cham, Springer., 2018
ISBN 10 : 3319925067 ISBN 13 : 9783319925066
Ancien ou d'occasion Couverture rigide

Vendeur : Universitätsbuchhandlung Herta Hold GmbH, Berlin, Allemagne

Évaluation du vendeur 4 sur 5 étoiles Evaluation 4 étoiles, En savoir plus sur les évaluations des vendeurs

x, 231 p. Hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Sprache: Englisch. N° de réf. du vendeur 4898BB

Contacter le vendeur

Acheter D'occasion

EUR 18
Autre devise
Frais de port : EUR 10
De Allemagne vers France
Destinations, frais et délais

Quantité disponible : 1 disponible(s)

Ajouter au panier

Image fournie par le vendeur

Ramkumar, Vickram|Rybak, Leonard P.
ISBN 10 : 3319925067 ISBN 13 : 9783319925066
Neuf Couverture rigide
impression à la demande

Vendeur : moluna, Greven, Allemagne

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Gebunden. Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Details several different aspects of the cochlear inflammatory processDiscusses recent clinical trials focusing on the use of anti-inflammatory agents for the treatment of drug, noise-induced and auto-immune mediated hearing loss. N° de réf. du vendeur 221458669

Contacter le vendeur

Acheter neuf

EUR 92,27
Autre devise
Frais de port : EUR 9,70
De Allemagne vers France
Destinations, frais et délais

Quantité disponible : Plus de 20 disponibles

Ajouter au panier

Image fournie par le vendeur

Leonard P. Rybak
ISBN 10 : 3319925067 ISBN 13 : 9783319925066
Neuf Couverture rigide

Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Buch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - Common forms of preventable hearing loss are drug and noise-induced hearing loss which are believed to be produced by a similar mechanism. The generation of reactive oxygen species appears to be a common mechanism mediating hearing loss produced by these different sources. As such, a number of laboratories have focused their research towards identifying the sources of ROS production in the cochlea following administration of chemotherapeutic agents or noise exposure. This led to the identification of ROS generating enzymes, such as xanthine oxidases, nitric oxide synthase, and NADPH oxidases which are activated and/or induced during the development of hearing loss. A consequence of these findings was the implementation of antioxidants in preclinical studies for the treatment of hearing loss. These antioxidants have provided different levels of protection in animal and human studies, but none of these have been approved by the US Food and Drug Administration for the treatmentof hearing loss. More recently, it was shown that noise-induced hearing loss was associated with recruitment of inflammatory cells and mediators in the cochlea. This finding would suggest that noise could produce injury to the cochlea which stimulates local and/or circulating inflammatory cells. A similar finding was observed in the cochlea following administration of the anticancer drug, cisplatin. In addition, our laboratory and others have provided a plausible mechanism by which noise or chemotherapeutic agents could stimulate the inflammatory response. Surprisingly, this mechanism involves ROS activation of transcription factors linked to inflammatory processes in the cochlea. These studies have led to the use of anti-inflammatory agents for the treatment of hearing loss. Preliminary studies targeting inflammatory cytokines appear especially promising in preclinical studies. A primary goal of this project is to describe our current understanding of theoxidant hypothesis of noise and drug-induced hearing loss and show how this relates to cochlear inflammation. Several different aspects of the cochlear inflammatory process will be discussed in detail, ranging from the sources of inflammatory cells, chemokines, inflammatory cytokines, and cochlea resident immune cells. Molecular pathways leading to activation of the local inflammatory process will be highlighted and treatment options will be discussed. The relevance of certain clinically used anti-inflammatory interventions, such as trans-typmanic steroids will also be discussed. Furthermore, we will examine recent patents focusing on the use of anti-inflammatory agents for the treatment of drug and noise-induced hearing loss. N° de réf. du vendeur 9783319925066

Contacter le vendeur

Acheter neuf

EUR 106,99
Autre devise
Frais de port : EUR 10,99
De Allemagne vers France
Destinations, frais et délais

Quantité disponible : 1 disponible(s)

Ajouter au panier

Image fournie par le vendeur

Leonard P. Rybak
ISBN 10 : 3319925067 ISBN 13 : 9783319925066
Neuf Couverture rigide
impression à la demande

Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Buch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware - Common forms of preventable hearing loss are drug and noise-induced hearing loss which are believed to be produced by a similar mechanism. The generation of reactive oxygen species appears to be a common mechanism mediating hearing loss produced by these different sources. As such, a number of laboratories have focused their research towards identifying the sources of ROS production in the cochlea following administration of chemotherapeutic agents or noise exposure. This led to the identification of ROS generating enzymes, such as xanthine oxidases, nitric oxide synthase, and NADPH oxidases which are activated and/or induced during the development of hearing loss. A consequence of these findings was the implementation of antioxidants in preclinical studies for the treatment of hearing loss. These antioxidants have provided different levels of protection in animal and human studies, but none of these have been approved by the US Food and Drug Administration for the treatment of hearing loss. More recently, it was shown that noise-induced hearing loss was associated with recruitment of inflammatory cells and mediators in the cochlea. This finding would suggest that noise could produce injury to the cochlea which stimulates local and/or circulating inflammatory cells. A similar finding was observed in the cochlea following administration of the anticancer drug, cisplatin. In addition, our laboratory and others have provided a plausible mechanism by which noise or chemotherapeutic agents could stimulate the inflammatory response. Surprisingly, this mechanism involves ROS activation of transcription factors linked to inflammatory processes in the cochlea. These studies have led to the use of anti-inflammatory agents for the treatment of hearing loss. Preliminary studies targeting inflammatory cytokines appear especially promising in preclinical studies. A primary goal of this project is to describe our current understanding of the oxidant hypothesis of noise and drug-induced hearing loss and show how this relates to cochlear inflammation. Several different aspects of the cochlear inflammatory process will be discussed in detail, ranging from the sources of inflammatory cells, chemokines, inflammatory cytokines, and cochlea resident immune cells. Molecular pathways leading to activation of the local inflammatory process will be highlighted and treatment options will be discussed. The relevance of certain clinically used anti-inflammatory interventions, such as trans-typmanic steroids will also be discussed. Furthermore, we will examine recent patents focusing on the use of anti-inflammatory agents for the treatment of drug and noise-induced hearing loss. 244 pp. Englisch. N° de réf. du vendeur 9783319925066

Contacter le vendeur

Acheter neuf

EUR 106,99
Autre devise
Frais de port : EUR 11
De Allemagne vers France
Destinations, frais et délais

Quantité disponible : 2 disponible(s)

Ajouter au panier

Image fournie par le vendeur

Leonard P. Rybak
ISBN 10 : 3319925067 ISBN 13 : 9783319925066
Neuf Couverture rigide

Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Buch. Etat : Neu. Neuware -Common forms of preventable hearing loss are drug and noise-induced hearing loss which are believed to be produced by a similar mechanism. The generation of reactive oxygen species appears to be a common mechanism mediating hearing loss produced by these different sources. As such, a number of laboratories have focused their research towards identifying the sources of ROS production in the cochlea following administration of chemotherapeutic agents or noise exposure. This led to the identification of ROS generating enzymes, such as xanthine oxidases, nitric oxide synthase, and NADPH oxidases which are activated and/or induced during the development of hearing loss. A consequence of these findings was the implementation of antioxidants in preclinical studies for the treatment of hearing loss. These antioxidants have provided different levels of protection in animal and human studies, but none of these have been approved by the US Food and Drug Administration for the treatmentof hearing loss.More recently, it was shown that noise-induced hearing loss was associated with recruitment of inflammatory cells and mediators in the cochlea. This finding would suggest that noise could produce injury to the cochlea which stimulates local and/or circulating inflammatory cells. A similar finding was observed in the cochlea following administration of the anticancer drug, cisplatin. In addition, our laboratory and others have provided a plausible mechanism by which noise or chemotherapeutic agents could stimulate the inflammatory response. Surprisingly, this mechanism involves ROS activation of transcription factors linked to inflammatory processes in the cochlea. These studies have led to the use of anti-inflammatory agents for the treatment of hearing loss. Preliminary studies targeting inflammatory cytokines appear especially promising in preclinical studies.A primary goal of this project is to describe our current understanding of theoxidant hypothesis of noise and drug-induced hearing loss and show how this relates to cochlear inflammation. Several different aspects of the cochlear inflammatory process will be discussed in detail, ranging from the sources of inflammatory cells, chemokines, inflammatory cytokines, and cochlea resident immune cells. Molecular pathways leading to activation of the local inflammatory process will be highlighted and treatment options will be discussed. The relevance of certain clinically used anti-inflammatory interventions, such as trans-typmanic steroids will also be discussed. Furthermore, we will examine recent patents focusing on the use of anti-inflammatory agents for the treatment of drug and noise-induced hearing loss.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 244 pp. Englisch. N° de réf. du vendeur 9783319925066

Contacter le vendeur

Acheter neuf

EUR 106,99
Autre devise
Frais de port : EUR 15
De Allemagne vers France
Destinations, frais et délais

Quantité disponible : 2 disponible(s)

Ajouter au panier

Image d'archives

Edité par Springer, 2018
ISBN 10 : 3319925067 ISBN 13 : 9783319925066
Neuf Couverture rigide

Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Etat : New. In. N° de réf. du vendeur ria9783319925066_new

Contacter le vendeur

Acheter neuf

EUR 119,30
Autre devise
Frais de port : EUR 4,73
De Royaume-Uni vers France
Destinations, frais et délais

Quantité disponible : Plus de 20 disponibles

Ajouter au panier

Image d'archives

Edité par Springer, 2018
ISBN 10 : 3319925067 ISBN 13 : 9783319925066
Neuf Couverture rigide

Vendeur : Books Puddle, New York, NY, Etats-Unis

Évaluation du vendeur 4 sur 5 étoiles Evaluation 4 étoiles, En savoir plus sur les évaluations des vendeurs

Etat : New. N° de réf. du vendeur 26376268002

Contacter le vendeur

Acheter neuf

EUR 139,68
Autre devise
Frais de port : EUR 7,88
De Etats-Unis vers France
Destinations, frais et délais

Quantité disponible : 4 disponible(s)

Ajouter au panier

Image d'archives

Edité par Springer, 2018
ISBN 10 : 3319925067 ISBN 13 : 9783319925066
Neuf Couverture rigide
impression à la demande

Vendeur : Majestic Books, Hounslow, Royaume-Uni

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Etat : New. Print on Demand. N° de réf. du vendeur 370858813

Contacter le vendeur

Acheter neuf

EUR 142,65
Autre devise
Frais de port : EUR 10,50
De Royaume-Uni vers France
Destinations, frais et délais

Quantité disponible : 4 disponible(s)

Ajouter au panier

Image d'archives

Edité par Springer, 2018
ISBN 10 : 3319925067 ISBN 13 : 9783319925066
Neuf Couverture rigide
impression à la demande

Vendeur : Biblios, Frankfurt am main, HESSE, Allemagne

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Etat : New. PRINT ON DEMAND. N° de réf. du vendeur 18376268008

Contacter le vendeur

Acheter neuf

EUR 147,32
Autre devise
Frais de port : EUR 7,95
De Allemagne vers France
Destinations, frais et délais

Quantité disponible : 4 disponible(s)

Ajouter au panier

Image d'archives

Ramkumar, Vickram (Editor)/ Rybak, Leonard (Editor)
Edité par Springer Verlag, 2018
ISBN 10 : 3319925067 ISBN 13 : 9783319925066
Neuf Couverture rigide

Vendeur : Revaluation Books, Exeter, Royaume-Uni

Évaluation du vendeur 5 sur 5 étoiles Evaluation 5 étoiles, En savoir plus sur les évaluations des vendeurs

Hardcover. Etat : Brand New. 244 pages. 9.25x6.10x0.67 inches. In Stock. N° de réf. du vendeur x-3319925067

Contacter le vendeur

Acheter neuf

EUR 155,78
Autre devise
Frais de port : EUR 11,86
De Royaume-Uni vers France
Destinations, frais et délais

Quantité disponible : 2 disponible(s)

Ajouter au panier

There are 1 autres exemplaires de ce livre sont disponibles

Afficher tous les résultats pour ce livre